

Cover Story
By Matthew Bin Han Ong
After an examination of the causes of an avalanche of grant applications directed at NCI, institute officials found that new applications largely come from principal investigators who are switching their research focus to cancer. No other NIH institute or center faces such pressure.
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


NCI Trials


NCI Trials for December 2019
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- House passes three-year extension of ACA subsidies with bipartisan support
- A planned randomized trial will ask an intriguing question: Do COVID vaccines potentiate checkpoint inhibitors?
- NIH agrees to review hundreds of denied or shelved grant applications
- MSK’s AML researcher Bayard “Barney” Clarkson, former president of ASCO and AACR, dies at 99
- Paul Engstrom, Fox Chase pioneer of cancer prevention, dies at 89
- Patient advocate David Mitchell, 75, dies of multiple myeloma















